Proteasome subunit beta type-7 (PSMB7)

The protein contains 277 amino acids for an estimated molecular weight of 29965 Da.

 

Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). Within the 20S core complex, PSMB7 displays a trypsin-like activity. (updated: Jan. 31, 2018)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Wilson and co-workers. (2016) Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation. Mol Cell Proteomics. 15(6), 1938-1946.
  5. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  6. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.
  7. Chu and co-workers. (2018) Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation. Br J Haematol. 180(1), 118-133.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 95%
Model score: 100
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
dbSNP:rs4574

Biological Process

Anaphase-promoting complex-dependent catabolic process GO Logo
Antigen processing and presentation of exogenous peptide antigen via MHC class I GO Logo
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO Logo
Antigen processing and presentation of peptide antigen via MHC class I GO Logo
Apoptotic process GO Logo
Cellular nitrogen compound metabolic process GO Logo
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest GO Logo
Fc-epsilon receptor signaling pathway GO Logo
G1/S transition of mitotic cell cycle GO Logo
Gene expression GO Logo
Interleukin-1-mediated signaling pathway GO Logo
MAPK cascade GO Logo
Mitotic cell cycle GO Logo
Negative regulation of apoptotic process GO Logo
Negative regulation of canonical Wnt signaling pathway GO Logo
Negative regulation of G2/M transition of mitotic cell cycle GO Logo
Neutrophil degranulation GO Logo
NIK/NF-kappaB signaling GO Logo
Obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle GO Logo
Obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition GO Logo
Obsolete regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle GO Logo
Positive regulation of canonical Wnt signaling pathway GO Logo
Positive regulation of protein targeting to mitochondrion GO Logo
Post-translational protein modification GO Logo
Pre-replicative complex assembly GO Logo
Proteasomal protein catabolic process GO Logo
Proteasomal ubiquitin-independent protein catabolic process GO Logo
Proteasome-mediated ubiquitin-dependent protein catabolic process GO Logo
Protein deubiquitination GO Logo
Protein polyubiquitination GO Logo
Proteolysis involved in cellular protein catabolic process GO Logo
Regulation of apoptotic process GO Logo
Regulation of cellular amino acid metabolic process GO Logo
Regulation of hematopoietic stem cell differentiation GO Logo
Regulation of mitotic cell cycle phase transition GO Logo
Regulation of mRNA stability GO Logo
Regulation of transcription from RNA polymerase II promoter in response to hypoxia GO Logo
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process GO Logo
Small molecule metabolic process GO Logo
Stimulatory C-type lectin receptor signaling pathway GO Logo
T cell receptor signaling pathway GO Logo
Transmembrane transport GO Logo
Tumor necrosis factor-mediated signaling pathway GO Logo
Viral process GO Logo
Wnt signaling pathway, planar cell polarity pathway GO Logo

The reference OMIM entry for this protein is 604030

Proteasome subunit, beta-type, 7; psmb7
Proteasome subunit z
Proteasome subunit beta-2

The 20S (700-kD) proteasome, which contains multiple peptidase activities, is one component of the 26S (2000-kD) complex, which degrades ubiquitinated proteins. The 20S proteasome is composed of alpha and proteolytic beta subunits. See PSMB2 (602175). One important function of the proteasome in higher vertebrates is to generate the peptides presented on MHC-class 1 molecules to circulating lymphocytes. The cytokine gamma-interferon (IFNG; 147570), which stimulates antigen presentation, alters proteasome subunit composition and functional activity. Upon IFNG treatment, the beta subunits X (600306) and Y (600307) are replaced by subunits LMP7 (177046) and LMP2 (177045), respectively. The changes in peptidase activity are due to the incorporation of the LMP subunits (Coux et al. (1996)). Hisamatsu et al. (1996) determined that a third pair of proteasome subunits, Z and MECL1 (176847), are expressed reciprocally in response to IFNG treatment. Z is downregulated, while MECL1 is markedly induced, suggesting that Z can be replaced by MECL1 in the proteasomal complex. By screening a HepG2 cell line library with a probe based on the partial amino acid sequence of the Z protein, the authors isolated cDNAs encoding Z. Sequence analysis revealed that the predicted 277-amino acid Z protein is a beta subunit. Z shares 58% and 55% protein sequence identity with MECL1 and PUP1, a S. cerevisiae proteasomal subunit, respectively. Both Z and MECL1 are proteolytically processed to generate a mature protein with an N-terminal threonine residue that is required for activity. Coux et al. (1996) stated that the IFNG-induced beta subunits MECL1, LMP7, and LMP2, likely alter peptidase activity because they contain distinct active sites. Thus the proteasomes from IFNG-treated cells should generate more peptides with hydrophobic or basic C termini, like the vast majority of peptides presented on MHC class I molecules. Hisamatsu et al. (1996) proposed that 20S particles containing MECL1, LMP7, and LMP2 be designated immunoproteasomes to emphasize their role in immunologic processing of endogenous antigens. By fluorescence in situ hybridization, Hisamatsu et al. (1996) mapped the Z gene to 9q34.11-q34.12. ... More on the omim web site

Subscribe to this protein entry history

Feb. 10, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 604030 was added.